Study Of Trivanga Bhasma to cure the Madhumehi (Diabetic) Patients
- Conditions
- Health Condition 1: - Health Condition 2: null- Patients having chief and associated complains of Madhumeha (Prabhuta Avilamutrata pipashadhikya kshudhadhikya etc) Known patient of Type 2 Diabetes Mellitus
- Registration Number
- CTRI/2018/03/012361
- Lead Sponsor
- Institute for Post Graduate Teaching and Research in Ayurved
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 89
1Both the sexes having age between 30 to 60 years.
2Patients having chief & associated complains of Madhumeha (Prabhuta-Avilamutrata, pipashadhikya, kshudhadhikya etc.)
3Known patient of Type 2 Diabetes Mellitus and also the preliminarily diagnosed patients based on signs and symptoms of the disease are confirmed by FBS and PPBS.
1Age more than 60 and below 30 years
2All patients of diabetes mellitus dependent on insulin.
3Malignant and accelerated hypertensive.
4CNS disorder e.g. encephalopathy
5Other chronic debilitating diseases like STD etc.
6Pregnant woman and planning to be pregnant within six month
7Lactating mothers.
8Secondary Diabetes mellitus
9Diabetic nephropathy
10End stage renal disease
11Non healing Diabetic ulcer (Diabetic foot)
12Other chronic debilitating diseases.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary end-point was symptomatic relief, reduction and control of NIDDM symptoms, polydipsia, polyuria, polyphagia, burning sensation in hands and soles, pain/ cramps, fasting and postprandial blood sugar levelsTimepoint: After 3 months trial drugs intervention. <br/ ><br>
- Secondary Outcome Measures
Name Time Method Trivanga Bhasma safety and toxicity profiles were secondary end points.Timepoint: 18 months